Brief: Shuttle Pharmaceuticals Engages Theradex Oncology In Preparation Of Clinical Study

Shuttle Pharmaceuticals Holdings

03/11/2022 14:18

Nov 3 (Reuters) - Shuttle Pharmaceuticals Inc  SHPH.O :
    * SHUTTLE PHARMACEUTICALS INC - ENGAGED THERADEX ONCOLOGY TO
HELP
PREPARE FOR ITS UPCOMING CLINICAL STUDY OF ROPIDOXURIDINE

Source text for Eikon:  ID:nPn297lhRa 
Further company coverage:  SHPH.O 
 ((Reuters.Briefs@thomsonreuters.com;))